Dor muscular abaixo do nível de lesão em paciente com lesão medular crônica: relato de caso
DOI:
https://doi.org/10.11606/issn.2317-0190.v29iSupl.1a204839Keywords:
Pain, Spinal Cord Injuries, Botulinum Toxins, Type AAbstract
No Brasil, estima-se que ocorram a cada ano no país, mais de 10 mil novos casos de lesão medular (LM).
Downloads
References
Brasil. Ministério da Saúde. Diretrizes de atenção à pessoa com lesão medular. Brasília: Ministério da Saúde; 2013.
De Andrés J, Cerda-Olmedo G, Valía JC, Monsalve V, Lopez-Alarcón, Minguez A. Use of botulinum toxin in the treatment of chronic myofascial pain. Clin J Pain. 2003;19(4):269-75. Doi: https://doi.org/10.1097/00002508-200307000-00011
Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology. 2007;68(15):1178-82. Doi: https://doi.org/10.1212/01.wnl.0000259085.61898.9e
Li L, Stoop R, Clijsen R, Hohenauer E, Fernández-de-Las-Peñas C, Huang Q, et al. Criteria used for the diagnosis of myofascial trigger points in clinical trials on physical therapy: updated systematic review. Clin J Pain. 2020;36(12):955-67. Doi: https://doi.org/10.1097/AJP.0000000000000875
Matak I, Bölcskei K, Bach-Rojecky L, Helyes Z. Mechanisms of Botulinum Toxin Type A Action on Pain. Toxins (Basel). 2019;11(8):459. Doi: https://doi.org/10.3390/toxins11080459
Nicholson B. Differential diagnosis: nociceptive and neuropathic pain. Am J Manag Care. 2006;12(9 Suppl):S256-62.
van Gorp S, Kessels AG, Joosten EA, van Kleef M, Patijn J. Pain prevalence and its determinants after spinal cord injury: a systematic review. Eur J Pain. 2015;19(1):5-14. Doi: https://doi.org/10.1002/ejp.522
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Acta Fisiátrica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
